4 roadblocks facing orphan medicines

4 roadblocks facing orphan medicines seeking to achieve market access in Europe: 1) disease knowledge and awareness, 2) Clinical evidence development, 3) Economic evidence development, 4) Operational challenges

Infographic showing the roadblocks facing orphan medicines seeking to achieve market access in Europe.

Leave a Reply